News

Myomo to Present H.C. Wainwright Virtual BioConnect 2021 Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, the Company’s chief executive officer, and David Henry, chief financial officer, will present at the H.C. Wainwright Virtual BioConnect 2021 Conference being held January 11-14, 2021. Read more >>
Read more...

Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team

Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer's disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company's new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix's Chief Financial Officer (CFO). Read more >>
Read more...

Congress Extends Student Loan Repayment Provision to 2025

Employers will be allowed to make tax-free contributions of up to $5,250 per employee annually toward eligible education expenses, including tuition or student loan assistance. The passage this week of the stimulus bill approved by Congress preserves the tax-free status of employer payments toward employee student loans through 2025, a marked difference from the year-end expiration date included in the Coronavirus Aid, Relief and Economic Security (CARES) Act... The CARES Act’s semi-permanent status meant fewer employers were willing to...
Read more...

Cognoptix Announces Formation of a New Board of Directors

Cognoptix is a breakthrough diagnostics company developing an innovative office-based device-drug system for the early detection of Alzheimer's disease (AD). As another milestone of the Series R restart, recapitalization, and revitalization, the company named a new Board of Directors (BOD) formed under the leadership of Dr. Susanne Wilke, Ph.D., Cognoptix' new President and CEO. Read more >>
Read more...